Moreover, underlying in vivo experimental models of pulmonary fibrosis demonstrated the key role of CCR4 ligands (primarily CCL17, but also CCL22) in tissue fibrosis, where blockade of CCL17 effects in mice resulted in lesion reduction (129). The gene discussed is CCL17; the disease is pulmonary fibrosis.